Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s583, 2025. DOI: 10.25251/ed52rz19. Disponível em: https://skin.dermsquared.com/skin/article/view/3493. Acesso em: 16 nov. 2025.